J. B. Chemicals & Pharmaceuticals Limited (NSE: JBCHEPHARM)

JBCHEPHARM Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	974.6	882.15	769.34	565.44	286.86	290.08
Short-Term Investments	3,194	67.7	0.85	1.06	-	-
Trading Asset Securities	-	3,647	1,922	-	6,650	3,338
Cash & Short-Term Investments	4,169	4,596	2,692	566.5	6,937	3,628
Cash Growth	5.99%	70.74%	375.20%	-91.83%	91.19%	-9.08%
Accounts Receivable	8,165	6,869	5,758	5,557	3,890	3,454
Other Receivables	-	160.06	275.92	411.27	290.23	109.08
Receivables	8,171	7,036	6,048	5,981	4,185	3,614
Inventory	5,437	5,025	4,305	4,100	3,474	2,747
Prepaid Expenses	-	163.23	167.05	120.4	122.56	79.82
Other Current Assets	1,356	1,713	2,069	1,764	807.15	663.26
Total Current Assets	19,133	18,533	15,280	12,532	15,526	10,732
Property, Plant & Equipment	6,417	6,349	5,764	5,668	5,697	5,842
Long-Term Investments	259.8	237.08	137.84	127.22	129.09	694.55
Goodwill	574.6	574.59	574.59	574.59	574.59	531.4
Other Intangible Assets	13,584	13,885	13,223	6,714	321.05	300.92
Long-Term Deferred Tax Assets	52.2	58.78	65.1	64.31	69.43	65.78
Other Long-Term Assets	269.7	298.2	486.97	386.74	58.93	14.2
Total Assets	40,294	39,941	35,539	26,074	22,381	18,206
Accounts Payable	3,425	3,563	2,386	2,245	1,869	1,680
Accrued Expenses	-	167.83	176.15	247.43	241.37	71.36
Short-Term Debt	-	153.43	280.18	263.15	326.45	294.94
Current Portion of Long-Term Debt	816.4	3,182	1,370	-	-	-
Current Portion of Leases	111.1	108.77	88.87	76.26	72.02	49.53
Current Income Taxes Payable	238.1	117.62	49.54	60.95	79.02	60.21
Current Unearned Revenue	-	12.19	11.83	17.06	16.6	16.49
Other Current Liabilities	1,629	1,378	1,181	927.51	848.05	960.51
Total Current Liabilities	6,219	8,682	5,544	3,837	3,453	3,133
Long-Term Debt	-	236.39	3,832	-	-	-
Long-Term Leases	74.6	96.38	153.21	206.18	51.41	12.29
Long-Term Unearned Revenue	16.9	16.99	24.93	31.66	49.32	59.68
Long-Term Deferred Tax Liabilities	1,641	1,492	1,028	475.59	567.67	547.18
Other Long-Term Liabilities	219.9	183.26	146.1	132.19	112.09	73.87
Total Liabilities	8,172	10,708	10,735	4,688	4,247	3,826
Common Stock	155.3	155.2	154.76	154.56	154.56	154.56
Additional Paid-In Capital	-	1,134	697.02	507.68	507.68	507.68
Retained Earnings	-	26,676	22,757	19,933	17,354	13,734
Comprehensive Income & Other	31,967	1,268	1,195	745.66	80.81	-41.06
Total Common Equity	32,122	29,233	24,804	21,341	18,097	14,355
Minority Interest	-	-	-	44.9	37.05	25.01
Shareholders' Equity	32,122	29,233	24,804	21,386	18,134	14,380
Total Liabilities & Equity	40,294	39,941	35,539	26,074	22,381	18,206
Total Debt	1,002	3,777	5,724	545.59	449.88	356.76
Net Cash (Debt)	3,167	819.79	-3,032	20.92	6,487	3,271
Net Cash Growth	-	-	-	-99.68%	98.28%	-12.35%
Net Cash Per Share	19.91	5.17	-19.36	0.14	41.97	20.56
Filing Date Shares Outstanding	155.31	155.19	154.76	154.56	154.56	154.56
Total Common Shares Outstanding	155.31	155.19	154.76	154.56	154.56	154.56
Working Capital	12,914	9,851	9,736	8,694	12,073	7,599
Book Value Per Share	206.83	188.37	160.28	138.07	117.09	92.87
Tangible Book Value	17,964	14,774	11,006	14,053	17,202	13,523
Tangible Book Value Per Share	115.67	95.20	71.12	90.92	111.29	87.49
Land	-	335.72	5.72	5.72	5.72	5.72
Buildings	-	3,111	2,925	2,833	2,696	2,715
Machinery	-	8,760	8,363	8,095	7,800	7,863
Construction In Progress	-	633.22	444.09	139.06	255.67	161.67

Source: S&P Capital IQ. Standard template. Financial Sources.